Demonstrating the value of highly innovative technologies with real-world evidence: an interview with Karen Facey, RWE4Decisions
In this interview, we speak with Karen Facey (University of Edinburgh, UK and RWE4Decisions Facilitator) to learn more about the work of the multi-stakeholder initiative, RWE4Decisions. On November 23, 2023, RWE4Decisions hosted its Annual Symposium on "Real-World Evidence over the Medicines’ Lifecycle to inform HTA/Payer decisions" in Brussels, Belgium. Please could you introduce yourself and give a brief overview of your career to date? Thanks for inviting me to take part in this interview. Briefly, I worked as a statistician in pharma and medicines regulation, before becoming CEO of the first national health technology assessment (HTA) agency in Scotland in...